Open AccessPentoxifylline improves the quality of life in type-2 diabetes foot syndrome
Author(s) -
Marwan S.M. Al-Nimer,
Rawa Ratha,
Taha Mahwi
Publication year - 2019
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.35.5.11
Subject(s) - medicine , pentoxifylline , type 2 diabetes , diabetic foot , foot (prosody) , diabetes mellitus , endocrinology , linguistics , philosophy
To evaluate the effect of pentoxifylline on the quality of life (QoL) in diabetic foot syndrome (DFS) by using Short Form-36 questionnaire, and in reference to the revised neuropathy disability score (RNDS) and grading of diabetic foot.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom